Authors/Disclosures
|
Dina R. Amrom, MD
(McGill University)
|
No disclosure on file |
|
Jina M. Youn, MD, MS
(Northshore University Hospital)
|
Dr. Youn has nothing to disclose. |
|
Annapurna Poduri, MD, MPH
|
An immediate family member of Dr. Poduri has or had stock in Beam Therapeutics. The institution of Dr. Poduri has received research support from NIH. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Nicholas Deconinck
|
Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Nicholas Deconinck has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Francois Dubeau, MD
(Montreal Neurological Hospital and Institute)
|
Dr. Dubeau has nothing to disclose. |
|
|
No disclosure on file |
|
William B. Dobyns, MD
|
No disclosure on file |
|
Christopher Walsh, MD, PhD
(Boston Children'S Hospital)
|
Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze therapeutics. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Third Rock Ventures. Dr. Walsh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Flagship Pioneering. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. |
|
Frederick Andermann, MD, FRCPC, FÂ鶹´«Ã½Ó³»
|
No disclosure on file |
|
Eva Andermann, MD, PhD
(Montreal Neurological Inst)
|
No disclosure on file |